Levofloxacine Biogaran

Levofloxacin, the active ingredient in Levofloxacine Biogaran, is a fluoroquinolone antibiotic presented as an oral dosage form for systemic use. It treats a range of bacterial infections in adult patients, including respiratory, urinary and skin infections.

GNH USA supplies Levofloxacine Biogaran as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacine Biogaran is a fluoroquinolone antibiotic used to treat bacterial infections affecting several organ systems. - Community‑acquired pneumonia: eradicates the causative pathogens and improves respiratory function. - Acute bacterial sinusitis: reduces sinus inflammation and clears infection. - Acute exacerbation of chronic bronchitis: shortens symptom duration and prevents complications. - Skin and soft‑tissue infections: eliminates skin‑associated bacteria and promotes healing. - Urinary tract infections: clears uropathogens and resolves urinary symptoms. - Prostatitis: penetrates prostatic tissue to eradicate infecting organisms.

Levofloxacine Biogaran may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild gastrointestinal upset. - Diarrhea: loose stools, sometimes watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Abdominal pain: cramping or discomfort. - Insomnia: difficulty falling or staying asleep.

Serious or Rare Side Effects: - Tendon rupture: sudden pain and loss of function, especially in the Achilles. - QT interval prolongation: risk of cardiac arrhythmias. - Severe allergic reactions: rash, swelling, or anaphylaxis. - Clostridioides difficile infection: severe colitis with watery diarrhea. - Hepatic toxicity: elevated liver enzymes or jaundice. - Peripheral neuropathy: numbness or tingling in extremities.

Before prescribing Levofloxacine Biogaran, clinicians should consider several safety measures. - Renal function assessment: adjust use in patients with impaired clearance. - Hypersensitivity screening: avoid in individuals with known fluoroquinolone allergy. - Tendon monitoring: advise patients to report tendon pain or swelling promptly. - QT‑prolongation caution: avoid in patients with existing cardiac conduction disorders. - Pregnancy and lactation: use only if benefits outweigh potential risks. - Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levofloxacine Biogaran can interact with other medicines, requiring careful management.

Major Interactions (Avoid): - Co‑administration with other fluoroquinolones: increased risk of toxicity. - Concurrent use of QT‑prolonging agents (e.g., quinidine, azithromycin): heightened arrhythmia risk. - Antacids or supplements containing magnesium/aluminum/iron: markedly reduce levofloxacin absorption.

Moderate Interactions (Monitor Closely): - Corticosteroids: elevated risk of tendon rupture. - Theophylline: potential increase in serum theophylline levels, requiring dose adjustment.